About Bio pharmazeutika werden
The latest generation of biotechnological medicines that are usually derived by living cell materials are revolutionizing how medical conditions are treated. Bio pharmazeutika is not made from chemicals like traditional small-molecule drugs. They are made from a variety of complex biological components.
Biopharmazeutika werden are produced using gentechnische production (GTP) from in cultured bacteria, mammalian cells such as the popular CHO-Zellen, or even plants, which can be cultivated using plant biotechnology (Pflanzenbiotechnologie). In contrast to traditional drugs that are made in the laboratory through chemical processes and processes, all biopharmazeutika are created inside living organisms and must therefore be distinguished by their individual atom-by-atom structure.
Because of their complexity, bio pharmazeutika werden cannot be replicated exactly by scientists. They are therefore referred as biosimilars, not generics. After the patent protection for the original drug expires, companies can create and sell their own versions, provided that they meet certain statutory requirements. These are called Biosimilar Guidelines.
Biopharmazeutika can be administered by mouth or as an ingredient in the manufacturing of a variety of therapeutic devices, such as polysaccharides, peptides and vaccines. These substances are recombined in the process of downstream processing of Biopharmazeutika to produce complex biologic drugs. Recombinant biopharmazeutika consists of insulin, interleukin and monoclonal antibodies.
www.genotec-frankfurt.de/bio-pharmazeutika-werden-zu-einer-anerkannten-form-der-alternativmedizin/